Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High or Medium Dose CoronaVac Booster in mRNA-Primed Adults
NCT05254236Phase 2Withdrawn
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Feb 2022
- Primary completion
- Mar 2022
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Biotech Ltd.. Planned start Feb 2022; status: withdrawn.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05254236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05254236.